Serum thymidine kinase 1 concentration as a prognostic factor of chemotherapy-treated non-Hodgkin’s lymphoma patients

Zhu-Lin Pan; Xing-Ying Ji; Yan-Min Shi; Ji Zhou; Ellen He; Sven Skog

首页> 外文期刊>Journal of Cancer Research and Clinical Oncology >Serum thymidine kinase 1 concentration as a prognostic factor of chemotherapy-treated non-Hodgkin’s lymphoma patients

【24h】

Serum thymidine kinase 1 concentration as a prognostic factor of chemotherapy-treated non-Hodgkin’s lymphoma patients

机译：血清胸苷激酶1浓度作为化疗治疗非霍奇金淋巴瘤患者的预后因素

获取原文

获取原文并翻译 | 示例

获取外文期刊封面目录资料

开具论文收录证明 >>

文献代查 >>

文献数据库（团队版） >>

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

Purpose This study was performed to examine possible use of thymidine kinase 1 concentration in serum (STK1) for prognosis of non-Hodgkin’s lymphoma patients following chemotherapy treatment.

机译：目的进行这项研究，以检查血清中胸腺嘧啶核苷激酶1（STK1）浓度可能用于化疗后非霍奇金淋巴瘤患者的预后。

著录项

来源
《Journal of Cancer Research and Clinical Oncology》 |2010年第8期|p.1193-1199|共7页
作者
Zhu-Lin Pan; Xing-Ying Ji; Yan-Min Shi; Ji Zhou; Ellen He; Sven Skog;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词
Thymidine kinase 1; Non; Hodgkin’s lymphoma; Chemotherapy; Enhanced chemiluminescent (ECL) dot; blot assay;

机译：胸苷激酶1;非霍奇金淋巴瘤化学疗法;增强化学发光（ECL）点;印迹分析;

相似文献

外文文献
中文文献
专利

1. Serum thymidine kinase 1 concentration as a prognostic factor of chemotherapy-treated non-Hodgkin's lymphoma patients. [J] . Pan ZL, Ji XY, Shi YM, Journal of Cancer Research and Clinical Oncology . 2010,第8期

机译：血清胸苷激酶1浓度作为化疗治疗的非霍奇金淋巴瘤患者的预后因素。
2. Serum soluble CD27, but not thymidine kinase, is an independent prognostic factor for outcome in indolent non-Hodgkin's lymphoma. [J] . Kok M, Bonfrer JM, Korse CM, Tumour biology : . 2003,第1期

机译：血清可溶性CD27（而非胸苷激酶）是惰性非霍奇金淋巴瘤预后的独立预后因素。
3. Serum thymidine kinase 1 concentration in Chinese patients with chronic lymphocytic leukemia and its correlation with other prognostic factors [J] . Wei Xu, Xin Cao, Kou-Rong Miao, International Journal of Hematology . 2009,第2期

机译：中国慢性淋巴细胞白血病患者血清胸腺嘧啶核苷激酶1的浓度及其与其他预后因素的关系
4. MONITORING THERAPY IN CANINE MALIGNANT LYMPHOMA AND LEUKEMIA WITH SERUM THYMIDINE KINASE 1 ACTIVITY - EVALUATION OF A NEW, FULLY AUTOMATED NON-RADIOMETRIC ASSAY [C] . Henrik von Euler, Patricio Rivera, Anne-Charlotte Aronsson, Annual conference of the Veterinary Cancer Society . 2008

机译：监测治疗犬恶性淋巴瘤和白血病患者血清胸苷激酶1活性 - 评价新的，全自动非辐射测定法
5. CREATINE KINASE ISOENZYMES IN SERUM. A. IN VITRO STUDIES WITH RAT CK-1 AND HUMAN SERUM. B. APPARENT MITOCHONDRIAL CREATINE KINASE IN THE SERUM OF A PATIENT WITH METASTATIC CANCER TO THE LIVER [D] . HEINZ, JOHN WALTER. 1981

机译：血清中的肌酐激酶同工酶。 A.大鼠CK-1和人血清的体外研究。 B.肝转移癌患者血清中的线粒体肌氨酸激酶
6. The Prognostic Significance of the Serum p53 Protein Concentration in Chinese Patients with Non-Hodgkin Lymphoma [O] . Min Zhou, Ling Cen, Tao Chen, 2012

机译：中国非霍奇金淋巴瘤患者血清中p53蛋白浓度的预后意义
7. The use of serum deoxythymidine kinase as a prognostic marker, and in the monitoring of patients with non-Hodgkin's lymphoma. [O] . Gronowitz, J. S., Hagberg, H., Källander, C. F., 1983

机译：使用血清脱氧胸苷激酶作为预后标志物，以及在监测非霍奇金淋巴瘤患者中的应用。

Serum thymidine kinase 1 concentration as a prognostic factor of chemotherapy-treated non-Hodgkin’s lymphoma patients

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅